Rheumatology Medical News about systemic vasculitides

Become a Member Today!
Register

Most Viewed Abstracts

1. Report Shows Shift in Starting Salaries for Physicians

2. Rapid correction of low vitamin D status in nursing home residents

3. 2008 Exclusive Survey—Earnings: Good news for primary care income

4. Medicare pay-for-reporting effort draws fire from frustrated doctors

5. Allopurinol-induced recurrent dress syndrome: Pathophysiology and treatment

Your Article Summary

See Latest Articles

(Click the title below to leave the MDLinx Network and go to the Journal's Website)

Mimics of primary systemic vasculitides
International Journal of Clinical Rheumatology, 10/21/09

Khasnis A et al. – The primary systemic vasculitides are well defined entities, but a number of diseases can imitate their clinical, laboratory, radiographic and histological features. Every attempt must be made to establish the diagnosis before indicated therapy is commenced. This will help to avoid therapeutic misadventures when managing patients with these complex diseases.

<< Previous
Can anti-TNF agents protect against rheumatoid...

Next >>
Prevalence of pulmonary arterial hypertension in an Australian...

Increased incidence of cardiovascular events in patients with antineutrophil cytoplasmic antibody-associated vasculitides: A matched-pair cohort study
Arthritis & Rheumatism, 11/05/09 Relevance Score: 64%

Measures of Response in Clinical Trials of Systemic Sclerosis: The Combined Response Index for Systemic Sclerosis (CRISS) and Outcome Measures in Pulmonary Arterial Hypertension Related to Systemic Sclerosis (EPOSS)
Journal of Rheumatology, 10/15/09 Relevance Score: 47%

Ten cases of systemic lupus erythematosus related to hepatitis B vaccine
Lupus, 11/09/09 Relevance Score: 46%

Safety of vaccination of patients with systemic lupus erythematosus
Lupus, 11/04/09 Relevance Score: 46%

Scleritis and Systemic Disease Association in a Community-Based Referral Practice
American Journal of Ophthalmology, 10/20/09 Relevance Score: 46%